MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202421085334 A) filed by Alkem Laboratories Limited on November 07, 2024, for Pharmaceutical Composition Comprising Semaglutide.
Inventors include Sehgal, Ashish; Anand, Chinmay; Bera, Piumitali; Kawalkar, Nitin; and Kushwaha, Shailendra Singh.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: ABSTRACT OF THE INVENTION Pharmaceutical composition comprising Semaglutide The present invention relates to pharmaceutical compositions comprising glucagon-like peptide-1 (GLP-1) receptor agonist and a permeation enhancer. In particular, the present invention provides stabilized pharmaceutical compositions comprising semaglutide and permeation enhancer selected from salcaprozate sodium, sodium caprylate or combination thereof and its process of preparation. The invention also relates to the use of said stable composition for the treatment of type 2 diabetes as well as a variety of other conditions.
Disclaimer: Curated by HT Syndication.
